CD8A and neoplasm: Interestingly, the impact of SVX vaccine on tumor growth was less strictly mediated by CD8+ T cells in the hA20 than in hCT26 tumor model, suggesting that other immune cells responsive to the survivin vaccine may participate to tumor control.